应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01066 威高股份
开市前 04-26 09:06:05
5.050
+0.000
0.00%
最高
5.050
最低
5.050
成交量
184.72万
今开
5.050
昨收
5.050
日振幅
0.00%
总市值
230.82亿
流通市值
228.38亿
总股本
45.71亿
成交额
930.86万
换手率
0.04%
流通股本
45.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
威高股份(01066)出现大手卖出95.08万股,成交价$4.81,涉资457.335万
阿斯达克财经 · 04-15
威高股份(01066)出现大手卖出95.08万股,成交价$4.81,涉资457.335万
南向资金4月12日净买入威高股份453.08万股 连续3日增持
自选股智能写手 · 04-15
南向资金4月12日净买入威高股份453.08万股 连续3日增持
威高股份04月12日主力资金流入96万元 连续3日加仓
自选股智能写手 · 04-12
威高股份04月12日主力资金流入96万元 连续3日加仓
集采阵痛至净利润分发下滑,出海或成为骨科耗材唯一出路?
智通财经网 · 04-11
集采阵痛至净利润分发下滑,出海或成为骨科耗材唯一出路?
威高股份(01066)出现大手成交300万股,成交价$4.675,涉资1.402千万
阿斯达克财经 · 04-10
威高股份(01066)出现大手成交300万股,成交价$4.675,涉资1.402千万
威高股份(01066)出现大手卖出85.64万股,成交价$4.58,涉资392.231万
阿斯达克财经 · 04-08
威高股份(01066)出现大手卖出85.64万股,成交价$4.58,涉资392.231万
星展:维持威高股份(01066)“买入”评级 目标价削至6.4港元
智通财经 · 04-08
星展:维持威高股份(01066)“买入”评级 目标价削至6.4港元
星展:下调威高股份目标价至6.4港元 维持“买入”评级
市场资讯 · 04-08
星展:下调威高股份目标价至6.4港元 维持“买入”评级
威高股份(1066.HK):集采和基数影响下业绩承压
国泰君安 · 04-07
威高股份(1066.HK):集采和基数影响下业绩承压
威高股份销售下滑,2024-2026年盈测下调,高盛维持“买入”评级
和讯网 · 04-03
威高股份销售下滑,2024-2026年盈测下调,高盛维持“买入”评级
高盛:下调威高股份目标价至8.7港元 维持“买入”评级
市场资讯 · 04-03
高盛:下调威高股份目标价至8.7港元 维持“买入”评级
《大行报告》高盛降威高股份(01066.HK)目标价8.7元 派息比率提升
阿斯达克财经 · 04-02
《大行报告》高盛降威高股份(01066.HK)目标价8.7元 派息比率提升
威高股份(01066)出现大手买入85.6万股,成交价$4.89,涉资418.584万
阿斯达克财经 · 04-02
威高股份(01066)出现大手买入85.6万股,成交价$4.89,涉资418.584万
大摩:予威高股份“与大市同步”评级 目标价降至6.6港元
新浪港股 · 03-28
大摩:予威高股份“与大市同步”评级 目标价降至6.6港元
大摩:下调威高股份目标价至6.6港元 评级“与大市同步”
市场资讯 · 03-28
大摩:下调威高股份目标价至6.6港元 评级“与大市同步”
威高股份盘中异动 早盘大幅拉升5.14%
自选股智能写手 · 03-27
威高股份盘中异动 早盘大幅拉升5.14%
威高股份(01066)上涨5.81%,报4.92元/股
金融界 · 03-27
威高股份(01066)上涨5.81%,报4.92元/股
威高股份(01066):威高骨科(688161.SH)2023年归母净利约1.12亿元 同比减少81.3% 每10股派1.2元
智通财经 · 03-26
威高股份(01066):威高骨科(688161.SH)2023年归母净利约1.12亿元 同比减少81.3% 每10股派1.2元
威高股份(01066)将于7月12日派发末期股息每股0.0943元
智通财经 · 03-26
威高股份(01066)将于7月12日派发末期股息每股0.0943元
【港股通】威高股份(01066)去年溢利降27.6%至20.02亿元人民币 拟派末期股息每股0.0943元
金吾财讯 · 03-26
【港股通】威高股份(01066)去年溢利降27.6%至20.02亿元人民币 拟派末期股息每股0.0943元
加载更多
公司概况
公司名称:
威高股份
所属市场:
SEHK
上市日期:
--
主营业务:
山东威高集团医用高分子制品股份有限公司主要从事一次性医用产品的研发、生产及销售业务。该公司通过其自有品牌“洁瑞”和“威高骨科”销售产品。该公司通过三个业务分部进行运营。一次性医疗器械产品分部生产及销售一次性使用耗材,如输液器、注射器及血袋。骨科产品分部生产及销售骨科产品。血液净化产品分部生产及销售血液净化产品及相关医疗设备。该公司也通过其子公司制造工业自动化设备及部件,以及提供物流仓储服务。
发行价格:
--
{"stockData":{"symbol":"01066","market":"HK","secType":"STK","nameCN":"威高股份","latestPrice":5.05,"timestamp":1714093501038,"preClose":5.05,"halted":0,"volume":1847200,"delay":0,"floatShares":4522332324,"shares":4570632324,"eps":0.47902468,"marketStatus":"开市前","marketStatusCode":1,"change":0,"latestTime":"04-26 09:06:05","open":5.05,"high":5.05,"low":5.05,"amount":9308594.959999999,"amplitude":0,"askPrice":5.14,"askSize":4800,"bidPrice":4.95,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":0.47461293378110736,"exchange":"SEHK","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714095000000},"adr":0,"adjPreClose":5.05,"dividendRate":0.035826,"openAndCloseTimeList":[[1714095000000,1714104000000],[1714107600000,1714118400000]],"volumeRatio":0,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01066","defaultTab":"news","newsList":[{"id":"2427002592","title":"威高股份(01066)出现大手卖出95.08万股,成交价$4.81,涉资457.335万","url":"https://stock-news.laohu8.com/highlight/detail?id=2427002592","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427002592?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:08","pubTimestamp":1713168480,"startTime":"0","endTime":"0","summary":"[大手成交]威高股份(01066)在下午04:08出现大手卖出,成交量为95.08万,成交价为港币$4.81,涉资457.335万。至目前为止,股价升1.05%,今日最高价为$4.87,而最低价为$4.58,总成交量为1.014千万股,总成交金额港币$4.873千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404152858/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427492092","title":"南向资金4月12日净买入威高股份453.08万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427492092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427492092?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:31","pubTimestamp":1713144671,"startTime":"0","endTime":"0","summary":"4月12日, 南向资金增持威高股份453.08万股,连续3日增持。截止当日收盘,港股通共持有威高股份37681.03万股,占流通股8.32%。威高股份近5个交易日上涨5.54%,港股通累计增持1094.80万股;近20个交易日下跌6.85%,港股通累计增持2391.73万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415094517877cfcad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415094517877cfcad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426270004","title":"威高股份04月12日主力资金流入96万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426270004","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426270004?lang=zh_cn&edition=full","pubTime":"2024-04-12 16:16","pubTimestamp":1712909819,"startTime":"0","endTime":"0","summary":"04月12日, 威高股份股价涨0.42%,报收4.76元,成交金额5701万元,换手率0.27%,振幅4.85%,量比0.95。威高股份今日主力资金净流入96万元,连续3日净流入,上一交易日主力净流入276万元,今日环比减少65.22%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为36.84%,平均涨幅为2.54%。该股近5个交易日上涨5.32%,主力资金累计净流入931万元;近20日主力资金累计净流入1228万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412161831876da12c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412161831876da12c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426280623","title":"集采阵痛至净利润分发下滑,出海或成为骨科耗材唯一出路?","url":"https://stock-news.laohu8.com/highlight/detail?id=2426280623","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2426280623?lang=zh_cn&edition=full","pubTime":"2024-04-11 16:12","pubTimestamp":1712823177,"startTime":"0","endTime":"0","summary":"国内企业有望凭借产品性价比优势在海外渗透率较低地区实现出海放量。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20240411/20240411161311_36791.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240411/20240411161311_36791.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101074.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426329438","title":"威高股份(01066)出现大手成交300万股,成交价$4.675,涉资1.402千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2426329438","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426329438?lang=zh_cn&edition=full","pubTime":"2024-04-10 13:28","pubTimestamp":1712726880,"startTime":"0","endTime":"0","summary":"[大手成交]威高股份(01066)在下午01:28出现大手成交,成交量为300万,成交价为港币$4.675,涉资1.402千万。至目前为止,股价无升跌,今日最高价为$4.72,而最低价为$4.53,总成交量为1.812千万股,总成交金额港币$8.468千万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404103355/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425243951","title":"威高股份(01066)出现大手卖出85.64万股,成交价$4.58,涉资392.231万","url":"https://stock-news.laohu8.com/highlight/detail?id=2425243951","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425243951?lang=zh_cn&edition=full","pubTime":"2024-04-08 16:08","pubTimestamp":1712563680,"startTime":"0","endTime":"0","summary":"[大手成交]威高股份(01066)在下午04:08出现大手卖出,成交量为85.64万,成交价为港币$4.58,涉资392.231万。至目前为止,股价升1.552%,今日最高价为$4.69,而最低价为$4.51,总成交量为874.155万股,总成交金额港币$3.997千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404083502/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425931461","title":"星展:维持威高股份(01066)“买入”评级 目标价削至6.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425931461","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425931461?lang=zh_cn&edition=full","pubTime":"2024-04-08 14:17","pubTimestamp":1712557076,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,星展发布研究报告称,维持威高股份(01066)“买入”评级,目标价从11.6港元下调至6.4港元。公司2023年盈利同比下跌27.6%,符合早前发表的盈警公告,主要由于带量采购政策导致不同业务的医疗器械及耗材产品价格下降,以及不再销售疫情相关产品所致。相应地该行将其2024至2025年盈利预测下调32%及35%。但该行指出,威高股份的股价年前至今已下跌37%,预期负面因素已充分反映在股价表现上,看好公司是中国领先的医用耗材和药品包装供应商,相信行业的减肥药发展趋势,将推动该公司药品包装需求增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099225.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425465936","title":"星展:下调威高股份目标价至6.4港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2425465936","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2425465936?lang=zh_cn&edition=full","pubTime":"2024-04-08 13:56","pubTimestamp":1712555760,"startTime":"0","endTime":"0","summary":"相应地星展将威高2024至2025年盈利预测下调32%及35%,目标价从11.6港元下调至6.4港元。惟该行指出,威高的股价年前至今已下跌37%,预期负面因素已充分反映在股价表现上,看好公司是中国领先的医用耗材和药品包装供应商,相信行业的减肥药发展趋势,将推动该公司药品包装需求增长,维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-04-08/doc-inarcany3347759.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-04-08/doc-inarcany3347759.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425660495","title":"威高股份(1066.HK):集采和基数影响下业绩承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2425660495","media":"国泰君安","top":-1,"share":"https://www.laohu8.com/m/news/2425660495?lang=zh_cn&edition=full","pubTime":"2024-04-07 14:31","pubTimestamp":1712471501,"startTime":"0","endTime":"0","summary":"本报告导读:2023 年在集采和基数影响下业绩承压,随着集采影响边际收窄,基数效应减退,2024年起有望回归正常增长节奏,维持增持评级。公司2023 全年实现营收132.29 亿元,同比下滑3.8%,归母净利润20.02 亿元,同比下滑27.6%,受集采和基数影响业绩承压。骨科板块受集采降价和脊柱渠道库存补差影响,实现收入12.7 亿元,同比下滑38%,预计2024 年有望企稳回升。药品包装板块受新冠疫苗包装订单高基数影响收入同比下滑4%至20.2 亿元,常规业务基本持平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240407143142874f0e97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240407143142874f0e97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424375854","title":"威高股份销售下滑,2024-2026年盈测下调,高盛维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2424375854","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2424375854?lang=zh_cn&edition=full","pubTime":"2024-04-03 11:45","pubTimestamp":1712115930,"startTime":"0","endTime":"0","summary":"快讯摘要高盛发布评级报告指出,威高股份去年下半年销售额同比下降5%至63亿元,纯利同比下降35%至8.04亿元。尽管符合早前的盈警预告,但今年全年增长预期与市场预期稍有差距,预计增幅将在5%至10%之间。鉴于此,高盛将威高股份2024年至2026年的每股盈测分别下调了2.5%、0.4%和3%,并将目标价从10港元下调至8.7港元,维持“买入”评级。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040313150187d8fb63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040313150187d8fb63&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424988837","title":"高盛:下调威高股份目标价至8.7港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2424988837","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2424988837?lang=zh_cn&edition=full","pubTime":"2024-04-03 11:26","pubTimestamp":1712114760,"startTime":"0","endTime":"0","summary":"高盛发表评级报告指,威高股份去年下半年销售按年跌5%至63亿元,纯利按年跌35%至8.04亿元,符合早前盈警预告,管理层提出今年全年增长按年升5%至10%指引,稍微低于预期,并将派息比率由30%提升至40%,考虑到公司现金流强劲。该行表示,将公司在2024年至26年的各年每股盈测分别调整为降2.5%、降0.4%及降3%,其目标价由10港元下调至8.7港元,维持其评级为“买入”。责任编辑:张倩","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403112636791ea184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403112636791ea184&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424061683","title":"《大行报告》高盛降威高股份(01066.HK)目标价8.7元 派息比率提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2424061683","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424061683?lang=zh_cn&edition=full","pubTime":"2024-04-02 15:55","pubTimestamp":1712044500,"startTime":"0","endTime":"0","summary":"高盛发表评级报告指,威高股份(01066.HK) 去年下半年销售按年跌5%至63亿元人民币,纯利按年跌35%至8.04亿元人民币,符合早前盈警预告,管理层提出今年全年增长按年升5%至10%指引,稍微低于预期,并将派息比率由30%提升至40%,考虑到公司现金流强劲。该行表示,将公司在2024年至26年的各年每股盈测分别调整为降2.5%、降0.4%及降3%,其目标价由10元下调至8.7元,维持其评级为“买入”。(ca/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-02 12:25。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20240308114639756_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20240308114639756_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1339605/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2424068346","title":"威高股份(01066)出现大手买入85.6万股,成交价$4.89,涉资418.584万","url":"https://stock-news.laohu8.com/highlight/detail?id=2424068346","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424068346?lang=zh_cn&edition=full","pubTime":"2024-04-02 15:03","pubTimestamp":1712041380,"startTime":"0","endTime":"0","summary":"[大手成交]威高股份(01066)在下午03:03出现大手买入,成交量为85.6万,成交价为港币$4.89,涉资418.584万。至目前为止,股价升0.205%,今日最高价为$5.03,而最低价为$4.8,总成交量为506.636万股,总成交金额港币$2.472千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404023154/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422130549","title":"大摩:予威高股份“与大市同步”评级 目标价降至6.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422130549","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422130549?lang=zh_cn&edition=full","pubTime":"2024-03-28 15:23","pubTimestamp":1711610580,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 大摩发布研究报告称,在业绩公布后将威高股份(01066)2024至2026年销售预测下调3%、6%和9%,未来三年同比增长预测分别为6%、5% 和5%,与管理层指引一致。在毛利率基本稳定和营运效率提高的情况下,该行预计未来三年的每股盈利同比增长9%,较之前预测下调11%。目标价相应由7.5港元降至6.6港元,评级“与大市同步”。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:史丽君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tob/2024-03-28/doc-inapwefr4542533.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2024-03-28/doc-inapwefr4542533.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422871051","title":"大摩:下调威高股份目标价至6.6港元 评级“与大市同步”","url":"https://stock-news.laohu8.com/highlight/detail?id=2422871051","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2422871051?lang=zh_cn&edition=full","pubTime":"2024-03-28 13:40","pubTimestamp":1711604400,"startTime":"0","endTime":"0","summary":"大摩发表报告指,在业绩公布后,将威高股份2024至2026年销售预测分别下调3%、6%和9%,未来三年按年增长预测分别为6%、5%和5%,与管理层指引一致。在毛利率基本稳定和营运效率提高的情况下,该行预计未来三年的每股盈利按年增长9%,较之前预测下调11%。目标价相应由7.5港元降至6.6港元,评级“与大市同步”。责任编辑:王其霖","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281340297a4fafef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281340297a4fafef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422601340","title":"威高股份盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422601340","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422601340?lang=zh_cn&edition=full","pubTime":"2024-03-27 09:37","pubTimestamp":1711503445,"startTime":"0","endTime":"0","summary":"2024年03月27日早盘09时37分,威高股份股票出现异动,股价快速拉升5.14%。威高股份股票所在的医疗设备及用品行业中,整体涨幅为0.00%。其相关个股中,威高股份、高视医疗、紫元元涨幅较大,振幅较大的相关个股有威高股份、微创机器人-B、爱康医疗,振幅分别为7.31%、6.31%、4.78%。消息层面,截至09时37分,威高股份股票正面舆情新闻比例25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327093726861e15b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327093726861e15b2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422878601","title":"威高股份(01066)上涨5.81%,报4.92元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422878601","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422878601?lang=zh_cn&edition=full","pubTime":"2024-03-27 09:36","pubTimestamp":1711503394,"startTime":"0","endTime":"0","summary":"3月27日,威高股份盘中上涨5.81%,截至09:36,报4.92元/股,成交1130.26万元。山东威高集团医用高分子制品股份有限公司及其附属公司主要从事一次性医疗器械的研发、生产和销售,产品包括医疗耗材、骨科材料和血液净化耗材及设备等。截至2023年年报,威高股份营业总收入132.29亿元、净利润20.02亿元。3月26日,2023年度末期每股派人民币0.0943元,除权除息日2024-06-03,派息日2024-07-12。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/27093640008759.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422569121","title":"威高股份(01066):威高骨科(688161.SH)2023年归母净利约1.12亿元 同比减少81.3% 每10股派1.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422569121","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422569121?lang=zh_cn&edition=full","pubTime":"2024-03-26 20:12","pubTimestamp":1711455132,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)公布威高骨科(688161.SH)2023年业绩,营业收入约12.835亿元,同比减少37.63%;归属于上市公司股东的净利润约1.12亿元,同比减少81.3%;基本每股收益0.28元,拟每10股派发现金红利1.20元。公告称,营业收入减少主要原因为带量采购执行引起产品出厂价格下降以及渠道存货补差给予进货价格折让影响,导致报告期营业收入减少。净利减少主要原因为带量采购执行引起产品出厂价格下降以及渠道存货补差给予进货价格折让影响,导致产品销售毛利率下降,从而导致报告期归属于上市公司股东净利润减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092668.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422668846","title":"威高股份(01066)将于7月12日派发末期股息每股0.0943元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422668846","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422668846?lang=zh_cn&edition=full","pubTime":"2024-03-26 16:48","pubTimestamp":1711442929,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)发布公告,该公司将于2024年7月12日派发末期股息每股人民币0.0943元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032616500687b6d38e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032616500687b6d38e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422001650","title":"【港股通】威高股份(01066)去年溢利降27.6%至20.02亿元人民币 拟派末期股息每股0.0943元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422001650","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2422001650?lang=zh_cn&edition=full","pubTime":"2024-03-26 16:46","pubTimestamp":1711442789,"startTime":"0","endTime":"0","summary":"金吾财讯 | 威高股份(01066)公布,2023年度,公司拥有人应占纯利约20.02亿元(人民币,下同),同比下降27.6%;基本每股盈利0.44元,去年同期为0.61元;董事建议派付末期股息每股人民币0.0943元。期内,公司实现收入132.29亿元,同比下降3.77%;毛利66.43亿元,同比下降9.07%。年内,医疗器械产品业务录得营业额约为67.28亿元,较去年增长2.4%;药品包装业务录得营业额约为20.24亿元,较去年下降3.9%;骨科业务营业额约为12.71亿元,较去年下降37.6%;介入业务录得营业额约为21.65亿元,较去年增长11.7%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210510/NGU2YmIyNjZiZDI1MDYyMzE2NTI5NjgxOA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210510/NGU2YmIyNjZiZDI1MDYyMzE2NTI5NjgxOA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1934083","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.weigaogroup.com","stockEarnings":[{"period":"1week","weight":0.0565},{"period":"1month","weight":0.086},{"period":"3month","weight":-0.0901},{"period":"6month","weight":-0.2796},{"period":"1year","weight":-0.6169},{"period":"ytd","weight":-0.3364}],"compareEarnings":[{"period":"1week","weight":0.0548},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0835},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1252},{"period":"ytd","weight":0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东威高集团医用高分子制品股份有限公司主要从事一次性医用产品的研发、生产及销售业务。该公司通过其自有品牌“洁瑞”和“威高骨科”销售产品。该公司通过三个业务分部进行运营。一次性医疗器械产品分部生产及销售一次性使用耗材,如输液器、注射器及血袋。骨科产品分部生产及销售骨科产品。血液净化产品分部生产及销售血液净化产品及相关医疗设备。该公司也通过其子公司制造工业自动化设备及部件,以及提供物流仓储服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.057883},{"month":2,"riseRate":0.571429,"avgChangeRate":0.010255},{"month":3,"riseRate":0.428571,"avgChangeRate":0.025121},{"month":4,"riseRate":0.714286,"avgChangeRate":0.023303},{"month":5,"riseRate":0.384615,"avgChangeRate":0.033575},{"month":6,"riseRate":0.615385,"avgChangeRate":0.004306},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.006103},{"month":8,"riseRate":0.428571,"avgChangeRate":0.015389},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.007758},{"month":10,"riseRate":0.5,"avgChangeRate":0.003001},{"month":11,"riseRate":0.642857,"avgChangeRate":0.006245},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.003195}],"exchange":"SEHK","name":"威高股份","nameEN":"WEIGAO GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高股份(01066)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高股份(01066)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高股份,01066,威高股份股票,威高股份股票老虎,威高股份股票老虎国际,威高股份行情,威高股份股票行情,威高股份股价,威高股份股市,威高股份股票价格,威高股份股票交易,威高股份股票购买,威高股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高股份(01066)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高股份(01066)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}